Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Baofukang suppositories for bacterial vaginosis
ChiCTR2400082587Phase 2Recruiting
- Sponsor
- Peking University Shenzhen Hospital
- Start
- Apr 2024
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised trial of baofukang shuan in bacterial vaginosis (BV) (4 arms), sponsored by Peking University Shenzhen Hospital. Primary endpoint: Clinical cure rate. Started Apr 2024; status: recruiting.
02
Drugs
baofukang shuan
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on ChiCTR2400082587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082587.